Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab
Article in Targeted Oncology (April 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal
Article in BMC Cancer (July 2022)
Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma
Article in Expert Review of Molecular Diagnostics (March 2022)